Please login to the form below

Not currently logged in
Email:
Password:

Shield Therapeutics’ CFO steps down

Richard Jones to leave the group in early 2017

Richard Jones is to step down from his position as chief financial officer at Shield Therapeutics early next year.

Jones joined the secondary care pharmaceutical specialist in 2010 as a non-executive director before taking on his current role a year later.

He brought nearly 30 years of financial management experience to the firm, with 16 years specialising in the healthcare sector.

Previously, Jones has served as a healthcare consultant for Grant Thornton's healthcare advisory practice, as a strategic advisory board member for Bionow and in a number of senior corporate finance roles specialising in healthcare.

Carl Sterritt, chief executive officer of Shield Therapeutics, said: “Richard has helped build the Group from its inception as a small private company through to being listed on AIM.

“I would like to thank him for his significant contribution to Shield and wish him the best in his future endeavours as we continue to grow rapidly into a commercial-stage specialty pharmaceutical business with international operations."


23rd November 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics